Sheath-enhanced concentration and on-chip detection of bacteria from an extremely low-concentration level
- PMID: 39688032
- PMCID: PMC12261496
- DOI: 10.1039/d4lc00698d
Sheath-enhanced concentration and on-chip detection of bacteria from an extremely low-concentration level
Abstract
Microfluidic-based sheath flow focusing methods have been widely used for efficiently isolating, concentrating, and detecting pathogenic bacteria for various biomedical applications due to their enhanced sensitivity and exceptional integration. However, such a microfluidic device usually needs complicated device fabrication and sample dilution, hampering the efficient and sensitive identification of target bacteria. In this study, we develop and fabricate a sheath-assisted and pneumatic-induced nano-sieve device for achieving the improved on-chip concentration and sensitive detection of Staphylococcus aureus (MRSA). The optimized nanochannel design with diverging configuration is beneficial to the regulation of the hydrodynamic flow while the sheath flow is focusing the sample to the confined region as expected. Per the experimental finding, a high flow ratio (sheath flow/sample flow) presents enhanced target concentration by comparing with a low flow ratio. With this setup, MRSA bacteria with an extremely low concentration of ∼100 CFU mL-1 are successfully and sensitively detected under a fluorescence microscope, less than 30 min, demonstrating a reliable sheath-enhanced concentration and on-chip detection for target bacteria. Additionally, the theoretical model introduced here further rationalizes the working principle of our nano-sieve device, potentially guiding the optimization of next generation devices for highly sensitive and accurate on-chip bacteria detection at a much lower concentration level below 100 CFU mL-1.
Conflict of interest statement
Conflicts of interest
There are no conflicts to declare.
Figures





Similar articles
-
Novel application of metabolic imaging of early embryos using a light-sheet on-a-chip device: a proof-of-concept study.Hum Reprod. 2025 Jan 1;40(1):41-55. doi: 10.1093/humrep/deae249. Hum Reprod. 2025. PMID: 39521726 Free PMC article.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
Automated devices for identifying peripheral arterial disease in people with leg ulceration: an evidence synthesis and cost-effectiveness analysis.Health Technol Assess. 2024 Aug;28(37):1-158. doi: 10.3310/TWCG3912. Health Technol Assess. 2024. PMID: 39186036 Free PMC article.
-
Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis.Cochrane Database Syst Rev. 2022 Dec 13;12(12):CD009650. doi: 10.1002/14651858.CD009650.pub5. Cochrane Database Syst Rev. 2022. PMID: 36511181 Free PMC article.
-
Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.Clin Orthop Relat Res. 2025 Jan 1;483(1):39-48. doi: 10.1097/CORR.0000000000003161. Epub 2024 Jun 21. Clin Orthop Relat Res. 2025. PMID: 38905450
References
-
- Hu W-C, Pang J, Biswas S, Wang K, Wang C and Xia X-H, Anal. Chem, 2021, 93, 8544–8552. - PubMed
-
- Riu J and Giussani B, TrAC, Trends Anal. Chem, 2020, 126, 115863.
-
- Nnachi RC, Sui N, Ke B, Luo Z, Bhalla N, He D and Yang Z, Environ. Int, 2022, 166, 107357. - PubMed
-
- Shen Y, Zhang Y, Gao ZF, Ye Y, Wu Q, Chen H-Y and Xu J-J, Nano Today, 2021, 38, 101121.
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical